Novel approach for discovering cancer drug targets
A next-generation spatial genomics technology has allowed scientists to link specific genes to complex tumour characteristics at a scale and resolution not previously possible.
List view / Grid view
In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which new candidate medications are discovered.
A next-generation spatial genomics technology has allowed scientists to link specific genes to complex tumour characteristics at a scale and resolution not previously possible.
Using CRISPR gene-editing technology, scientists have developed a vaccine designed to prevent infection by Leishmania major.
Scientists from Northwestern University have developed a new technology platform that could bring individualised cell therapies to cancer patients.
Sino Biological, Inc. has announced the formation of two new operationally focused subsidiaries in China.
Researchers from the University of Pennsylvania may have discovered how to eliminate the risk of weight gain from certain diabetes medications by uncovering the difference between two varieties of a protein.
A new study has showed how a bioengineered RSV protein vaccine can induce a protective immune response in animal models.
Scientists have found a way to “supercharge” tumour-attacking T cells, which could improve the effectiveness of cell-based cancer immunotherapy and expand the number of cancers it can treat.
Researchers from the Technical University of Munich have successfully used specific enzymes to destroy the genetic information of SARS-CoV-2 directly after the virus enters a cell.
A recent paper highlights how tiny robots with living parts can be designed to effectively deliver drugs to body tissues.
A study has shown how Parkinson’s disease may be driven by cell stress-related biochemical events that disrupt a key cellular clean-up system.
MIT chemists have discovered a possible way to design drugs that could fight against drug resistance.
Researchers at Mayo Clinic, US found that messenger RNA could be used at low doses to regenerate bones without side effects.
Listen to this podcast to discover why mAbs are key in the fight against SARS-CoV-2 and how the pandemic has shaped their development pipeline.
Researchers have identified potential age-related macular degeneration drugs using a novel stem-cell based research tool.
Using virtual screening, researchers have discovered several natural compounds that could inhibit the SARS-CoV-2 main protease.